当前位置: X-MOL 学术Signal Transduct. Target Ther. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
APOE interacts with ACE2 inhibiting SARS-CoV-2 cellular entry and inflammation in COVID-19 patients
Signal Transduction and Targeted Therapy ( IF 40.8 ) Pub Date : 2022-08-01 , DOI: 10.1038/s41392-022-01118-4
Hongsheng Zhang 1, 2 , Lin Shao 3 , Zhihao Lin 3 , Quan-Xin Long 4 , Huilong Yuan 3 , Lujian Cai 3 , Guangtong Jiang 3 , Xiaoyi Guo 3 , Renzhi Yang 2 , Zepeng Zhang 1 , Bingchang Zhang 1 , Fan Liu 1 , Zhiyong Li 1 , Qilin Ma 1 , Yun-Wu Zhang 1, 3 , Ai-Long Huang 4 , Zhanxiang Wang 1 , Yingjun Zhao 1, 3 , Huaxi Xu 1, 2
Affiliation  

Apolipoprotein E (APOE) plays a pivotal role in lipid including cholesterol metabolism. The APOE ε4 (APOE4) allele is a major genetic risk factor for Alzheimer’s and cardiovascular diseases. Although APOE has recently been associated with increased susceptibility to infections of several viruses, whether and how APOE and its isoforms affect SARS-CoV-2 infection remains unclear. Here, we show that serum concentrations of APOE correlate inversely with levels of cytokine/chemokine in 73 COVID-19 patients. Utilizing multiple protein interaction assays, we demonstrate that APOE3 and APOE4 interact with the SARS-CoV-2 receptor ACE2; and APOE/ACE2 interactions require zinc metallopeptidase domain of ACE2, a key docking site for SARS-CoV-2 Spike protein. In addition, immuno-imaging assays using confocal, super-resolution, and transmission electron microscopies reveal that both APOE3 and APOE4 reduce ACE2/Spike-mediated viral entry into cells. Interestingly, while having a comparable binding affinity to ACE2, APOE4 inhibits viral entry to a lesser extent compared to APOE3, which is likely due to APOE4’s more compact structure and smaller spatial obstacle to compete against Spike binding to ACE2. Furthermore, APOE ε4 carriers clinically correlate with increased SARS-CoV-2 infection and elevated serum inflammatory factors in 142 COVID-19 patients assessed. Our study suggests a regulatory mechanism underlying SARS-CoV-2 infection through APOE interactions with ACE2, which may explain in part increased COVID-19 infection and disease severity in APOE ε4 carriers.



中文翻译:

APOE 与 ACE2 相互作用,抑制 COVID-19 患者的 SARS-CoV-2 细胞进入和炎症

载脂蛋白 E (APOE) 在包括胆固醇代谢在内的脂质中起关键作用。APOE ε4(APOE4) 等位基因是阿尔茨海默病和心血管疾病的主要遗传风险因素。尽管最近 APOE 与几种病毒感染的易感性增加有关,但 APOE 及其同种型是否以及如何影响 SARS-CoV-2 感染仍不清楚。在这里,我们展示了 73 名 COVID-19 患者的血清 APOE 浓度与细胞因子/趋化因子水平成反比。利用多种蛋白质相互作用分析,我们证明 APOE3 和 APOE4 与 SARS-CoV-2 受体 ACE2 相互作用;和 APOE/ACE2 相互作用需要 ACE2 的锌金属肽酶结构域,这是 SARS-CoV-2 刺突蛋白的关键对接位点。此外,使用共聚焦、超分辨率和透射电子显微镜的免疫成像分析表明,APOE3 和 APOE4 都可减少 ACE2/Spike 介导的病毒进入细胞。有趣的是,虽然 APOE4 与 ACE2 具有相当的结合亲和力,但与 APOE3 相比,APOE4 对病毒进入的抑制程度较小,这可能是由于 APOE4 的结构更紧凑,并且与 Spike 与 ACE2 的结合竞争的空间障碍更小。此外,在评估的 142 名 COVID-19 患者中, APOE ε4携带者在临床上与 SARS-CoV-2 感染增加和血清炎症因子升高相关。我们的研究提出了通过 APOE 与 ACE2 相互作用来感染 SARS-CoV-2 的调控机制,这可能部分解释了APOE ε4携带者中 COVID-19 感染和疾病严重程度的增加。

更新日期:2022-08-01
down
wechat
bug